Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,6613,680 of 20,252 grants

Active NON-SBIR/STTR RPGS
SUMOylation disruption is toxic for SS18-SSX-driven synovial sarcoma
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2028

Project Summary: Synovial Sarcoma (SS) is driven by the SS18-SSX oncofusion, and SS18-SSX is the only reoccurring mutation in SS. SS normally metastasizes, resulting in a 15-year o...

$5.71M
USD
Active NON-SBIR/STTR RPGS
In vivo Evaluation of Lymph Nodes Using Quantitative Ultrasound
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

Project Summary This application proposes a collaborative study to be performed by Weill Cornell Medicine (WCM) in New York, NY, as the lead organization in collaboration with GE R...

$6.67M
USD
Completed OTHER RESEARCH-RELATED
Investigating the interplay between senescence and T cell immunity
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT CANDIDATE: One of my long-standing interests is to understand the mediators of a successful antitumoral T cell response. In this application, I am proposin...

$1.43M
USD
Completed SBIR-STTR RPGS
CELL EXPANSION BIOREACTORS FOR ASSAY-READY IMMUNOCOMPETENT PATIENT MODELS
NATIONAL CANCER INSTITUTE Link Biosystems Inc United States 2023 – 2025

Project Summary/Abstract Although cancer is a leading cause of death globally, oncology drugs have the lowest success rates, cost the most to develop, and constantly show promising...

$3.28M
USD
Completed SBIR-STTR RPGS
Integration of non-invasive deep tissue microwave thermometry in the VectRx hyperthermia device in a transgenic liver tumor pig model
NATIONAL CANCER INSTITUTE Neotherma Oncology, Inc United States 2023 – 2024

Project Summary/Abstract NeoTherma Oncology (NTO/www.neothermaoncology.com) has developed a novel non-invasive medical device that delivers mild hyperthermia (HT) loco-regionally a...

$4M
USD
Active NON-SBIR/STTR RPGS
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2023 – 2028

PROJECT SUMMARY Blood CD8+ T cells can be subdivided into different subsets based on their cytokine section profiles and functions. We have shown that IL-9-secreting CD8+ Tc9 cells...

$4.73M
USD
Active NON-SBIR/STTR RPGS
Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy
NATIONAL CANCER INSTITUTE University of Illinois At Urbana-Champai... United States 2023 – 2026

Abstract While a growing arsenal of drugs is available to treat specific molecular abnormalities across cancers, therapy effectiveness can now be predicted by detecting specific ge...

$3.91M
USD
Active OTHER RESEARCH-RELATED
Decoding the epigenetic landscape that delineates T cell homeostatic proliferation from uncontrolled growth”
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2023 – 2028

PROJECT SUMMARY Epigenetic reinforcement of T cell exhaustion is a well-established barrier limiting multiple modalities of T cell- based immunotherapies for cancer. This proposal...

$2.64M
USD
Completed OTHER RESEARCH-RELATED
Fast-kinetics approaches to define direct gene-regulatory functions of MYB in leukemia
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2023

Project Summary/Abstract Acute myeloid leukemia (AML) remains a therapeutic challenge and a significant public health burden, necessitating development of novel therapies. The tran...

$2.21M
USD
Completed OTHER RESEARCH-RELATED
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2025

PROJECT SUMMARY The decreased quality of life and increased morbidity due to oncological drugs such as Tyrosine Kinase Inhibitors (TKIs) is a serious and growing general health pro...

$1.22M
USD
Active OTHER RESEARCH-RELATED
Assessment of a Radiomics-Based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT This proposal describes a comprehensive 5-year mentored career development plan with the goal of training the candidate to become a leading independent phy...

$2.5M
USD
Active NON-SBIR/STTR RPGS
Personalized neuroblastoma vaccines
NATIONAL CANCER INSTITUTE Children'S Hosp of Philadelphia United States 2023 – 2028

PROJECT SUMMARY This Multiple Principal Investigator (MPI) Project proposal for the Pediatric Immunotherapy Network is focused on high-risk neuroblastoma, a diverse and enigmatic m...

$8.39M
USD
Active NON-SBIR/STTR RPGS
HIGHLY SELECTIVE MACROBIOMOLECULAR ISOLATION, SOFT-LANDING AND CHARACTERIZATION USING STRUCTURES FOR LOSSLESS ION MANIPULATIONS
NATIONAL CANCER INSTITUTE Battelle Pacific Northwest Laboratories United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT (30 lines) This project aims to address the current gap in technology for rapid and comprehensive (mass, structure) profiling of biomacromolecules. While h...

$4.07M
USD
Active NON-SBIR/STTR RPGS
Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myeloma
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2028

PROJECT SUMMARY Multiple myeloma (MM) affects ~35,000 adult patients in the United States and causes ~12,000 deaths each year. Novel immunomodulatory drugs and effective multidrug...

$6.92M
USD
Active NON-SBIR/STTR RPGS
A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches.
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2023 – 2026

PROJECT SUMMARY The tumor microenvironment (TME) in essentially all epithelial cancers is associated with significant biochemical and structural changes in the extracellular matrix...

$2.08M
USD
Completed NON-SBIR/STTR RPGS
Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapy
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2023 – 2025

Project Summary While impressive progress has been made in tumor immunology and clinical application of immunomodulatory agents in solid tumors, we don’t fully understand how to ef...

$2.71M
USD
Active NON-SBIR/STTR RPGS
ATR: targeting mechanical stress induced EMT and immune suppression in triple negative breast cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2028

PROJECT DESCRIPTION/ABSTRACT Therapeutically resistant triple negative breast cancer (TNBC) is characterized by mesenchymal features that facilitate immune evasion and disease prog...

$3.69M
USD
Active NON-SBIR/STTR RPGS
Evaluating a remotely delivered, digital health CRC screening intervention among racially diverse patients of a community health center
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2023 – 2028

Project Summary/Abstract Colorectal cancer (CRC) screening is one of the most effective tools to reduce cancer morbidity and mortality. Yet, CRC screening rates at federally qualif...

$6.51M
USD
Active NON-SBIR/STTR RPGS
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2023 – 2028

ABSTRACT Targeted cancer therapy, in the form of tyrosine kinase inhibitors, has been a game changer for patients with cancers driven by activating mutations in genes encoding thes...

$5.58M
USD
Active OTHER RESEARCH-RELATED
Harnessing the repetitive genome for cancer immunotherapy
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARYThis KOS proposal describes a five-year career development training program in cancer epigenetics and tumor immunology. Dr. Gabriel Griffin has completed clinical tr...

$2.69M
USD